Research, Select, & Monitor Tuesday, February 20, 2018 5:59:48 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
ImmunoCellular Therapeutics Ltd$0.24   

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  ImmunoCellular Therapeutics Ltd vs Chemicals - Major Diversified

ImmunoCellular Therapeutics, Ltd. operates as a development stage company with primary focus on the development and commercialization of new therapeutics to fight cancer using the immune system. Its product candidate portfolio includes cellular immunotherapies targeting cancer and cancer stem cell antigens, peptide based immunotherapies targeting cancer stem cells, and monoclonal antibodies to diagnose and treat several different cancers. ImmunoCellular Therapeutics, Ltd. is based in California, USA.

Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: N/A $35,313.6 Mil
  Market Cap: $8.4 Mil $232,608.5 Mil
  Analysts Recommendation: N/A Buy

 Averages Company Industry
  Historic Revenue: N/A 3.6%
  Estimated Revenue: N/A 7.3%
  Historic Earnings: N/A 4.1%
  Estimated Earnings: N/A 11.7%
  Stock Price (1 Year): (91.3%) 20.2%
  Cash per Share: N/A 67.0%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: N/A 16.3
  Price-to-Sales: N/A N/A
  Price-to-Book: N/A 5.1
  Dividend Yield: N/A N/A
  Market Cap: $8.4 Mil $25,845.4 Mil
  Net Margin: N/A 14.3%
  Gross Margin: N/A 33.0%
  Return on Equity: N/A .2
  Return on Assets: N/A .1
  Balance Sheet
  Current Ratio: N/A 1.7
  Quick Ratio: N/A 1.5
  Cash Ratio: N/A .8
  Debt-to-Equity: N/A 1.5
  Interest Coverage: N/A .3
  Relative-Strength Index: 36.8 N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $25.32 $54,065.3 Mil
  Praxair, Inc.  (PX) $153.61 $43,980.1 Mil
  Air Products & Chemicals, Inc.  (APD) $163.63 $36,064.1 Mil
  Henkel KGaA  (HENKY) $124.32 $32,298.3 Mil
  Akzo Nobel N.V.  (AKZOY) $32.51 $24,592.2 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2018 All rights reserved.